Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AIM ImmunoTech Inc. (HEB)
|
Add to portfolio |
|
|
|
| Price: |
$2.16
| | Metrics |
| OS: |
48.7
|
M
| |
|
|
| Market cap: |
$105
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$0.63
| |
3.42
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.1 | 0.1 | 0.2 | 0.1 | 0.4 | 0.4 | 0.1 | 0.1 |
| Revenue growth | 4.4% | -17.2% | 16.4% | -61.9% | -16.0% | 375.0% | -30.8% | -32.5% |
| Cost of goods sold | 20.1 | 0.6 | 0.8 | 0.9 | 0.9 | 1.2 | 1.1 | 1.6 |
| Gross profit | -19.9 | -0.5 | -0.6 | -0.8 | -0.5 | -0.7 | -1.0 | -1.5 |
| Gross margin | -14129.8% | -369.6% | -394.5% | -537.9% | -140.9% | -170.7% | -1104.3% | -1101.5% |
| Research and development | 7.0 | 7.7 | 5.7 | 4.7 | 4.8 | 4.1 | 5.1 | 8.0 |
| General and administrative | 13.1 | 8.7 | 8.7 | 7.0 | 6.2 | 6.6 | 7.7 | 7.1 |
| EBITA | -19.7 | -16.7 | -14.9 | -12.4 | -11.5 | -11.4 | -13.8 | -16.6 |
| EBITA margin | -13973.0% | -12390.4% | -9171.2% | -8847.1% | -3126.4% | -2599.5% | -14950.0% | -12493.2% |
| Amortization of intangibles | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 |
| EBIT | -19.9 | -16.8 | -15.0 | -12.4 | -11.5 | -11.4 | -13.8 | -16.7 |
| EBIT margin | -14127.7% | -12476.3% | -9212.9% | -8887.9% | -3132.4% | -2612.4% | -15004.3% | -12518.8% |
| Pre-tax income | -19.4 | -19.1 | -14.4 | -9.4 | -9.8 | -8.3 | -7.5 | -15.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -19.4 | -19.1 | -14.4 | -9.4 | -9.8 | -8.3 | -7.5 | -15.2 |
| Net margin | -13790.8% | -14168.1% | -8834.4% | -6717.1% | -2677.7% | -1889.9% | -8154.3% | -11451.1% |
| |
| Diluted EPS | ($0.40) | ($0.40) | ($0.45) | ($2.58) | ($9.78) | ($0.29) | ($0.34) | ($0.77) |
| Shares outstanding (diluted) | 48.6 | 47.8 | 31.8 | 3.6 | 1.0 | 28.7 | 21.8 | 19.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|